| Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: a randomised trial (DolPHIN-1 study) C Waitt, C Orrell, S Walimbwa, Y Singh, K Kintu, B Simmons, ... PLoS medicine 16 (9), e1002895, 2019 | 73 | 2019 |
| The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva A Amara, SD Penchala, L Else, C Hale, R FitzGerald, L Walker, R Lyons, ... Journal of pharmaceutical and biomedical analysis 206, 114356, 2021 | 69 | 2021 |
| Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin NB Roberts, AB Amara, M Morris, BN Green Clinical chemistry 47 (2), 316-321, 2001 | 59 | 2001 |
| Pharmacogenetics of pregnancy‐induced changes in efavirenz pharmacokinetics A Olagunju, O Bolaji, A Amara, L Else, O Okafor, E Adejuyigbe, J Oyigboja, ... Clinical Pharmacology & Therapeutics 97 (3), 298-306, 2015 | 53 | 2015 |
| Albumin overload induces adaptive responses in human proximal tubular cells through oxidative stress but not via angiotensin II type 1 receptor L Shalamanova, F McArdle, AB Amara, MJ Jackson, R Rustom American Journal of Physiology-Renal Physiology 292 (6), F1846-F1857, 2007 | 48 | 2007 |
| Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 study LJ Else, A Jackson, R Puls, A Hill, P Fahey, E Lin, A Amara, M Siccardi, ... Antimicrobial agents and chemotherapy 56 (3), 1427-1433, 2012 | 46 | 2012 |
| Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS A Olagunju, OO Bolaji, A Amara, C Waitt, L Else, J Soyinka, B Adeagbo, ... Journal of Antimicrobial Chemotherapy 70 (2), 555-561, 2015 | 44 | 2015 |
| Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational study A Olagunju, O Bolaji, A Amara, C Waitt, L Else, E Adejuyigbe, M Siccardi, ... Clinical Infectious Diseases 61 (3), 453-463, 2015 | 43 | 2015 |
| Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation M Boffito, A Jackson, A Amara, D Back, S Khoo, C Higgs, N Seymour, ... Antimicrobial agents and chemotherapy 55 (9), 4218-4223, 2011 | 43 | 2011 |
| Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake E Elliot, A Amara, A Jackson, G Moyle, L Else, S Khoo, D Back, A Owen, ... Journal of Antimicrobial Chemotherapy 71 (4), 1031-1036, 2016 | 41 | 2016 |
| The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma SD Penchala, S Fawcett, L Else, D Egan, A Amara, E Elliot, E Challenger, ... Journal of Chromatography B 1027, 174-180, 2016 | 39 | 2016 |
| Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial A Winston, J Amin, A Clarke, L Else, A Amara, A Owen, T Barber, ... Clinical Infectious Diseases 60 (7), 1026-1032, 2015 | 38 | 2015 |
| Effect of food on the steady-state pharmacokinetics of tenofovir and emtricitabine plus efavirenz in Ugandan adults M Lamorde, P Byakika-Kibwika, WS Tamale, F Kiweewa, M Ryan, ... AIDS research and treatment 2012, 2012 | 38 | 2012 |
| A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography–mass spectrometry AB Amara, LJ Else, J Tjia, A Olagunju, RL Puls, S Khoo, DJ Back Therapeutic drug monitoring 37 (2), 220-228, 2015 | 32 | 2015 |
| Plasma tenofovir, emtricitabine, and rilpivirine and intracellular tenofovir diphosphate and emtricitabine triphosphate pharmacokinetics following drug intake cessation L Dickinson, HM Yapa, A Jackson, G Moyle, L Else, A Amara, S Khoo, ... Antimicrobial Agents and Chemotherapy 59 (10), 6080-6086, 2015 | 29 | 2015 |
| Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk … C Waitt, SD Penchala, A Olagunju, A Amara, L Else, M Lamorde, S Khoo Journal of Chromatography B 1060, 300-307, 2017 | 28 | 2017 |
| Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots A Olagunju, A Amara, C Waitt, L Else, SD Penchala, O Bolaji, J Soyinka, ... Journal of Antimicrobial Chemotherapy 70 (10), 2816-2822, 2015 | 28 | 2015 |
| A validated method for quantification of dolutegravir using ultra performance liquid chromatography coupled with UV detection X Wang, SD Penchala, A Amara, L Else, M McClure, M Boffito Therapeutic drug monitoring 38 (3), 327-331, 2016 | 27 | 2016 |
| Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine SI Walimbwa, M Lamorde, C Waitt, J Kaboggoza, L Else, ... Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 01310-18, 2019 | 23 | 2019 |
| Calcineurin inhibitors and proximal renal tubular injury in renal transplant patients with proteinuria and chronic allograft nephropathy JM Bone, AB Amara, A Shenkin, A Hammad, RA Sells, JL Alexander, ... Transplantation 79 (1), 119-122, 2005 | 23 | 2005 |
